ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

KMK Kromek Group Plc

7.25
0.40 (5.84%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 5.84% 7.25 7.00 7.50 7.25 6.85 6.85 1,554,889 16:18:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -7.11 43.52M

Kromek Group PLC Publication of Annual Report (5833K)

10/07/2017 12:00pm

UK Regulatory


Kromek (LSE:KMK)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Kromek Charts.

TIDMKMK

RNS Number : 5833K

Kromek Group PLC

10 July 2017

10th July 2017

Kromek Group plc

("Kromek" or the "Group")

Publication of Annual Report

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security screening and nuclear markets, announces that its annual report and accounts for the year ended 30 April 2017 has been made available on its website at www.kromek.com and will be posted to shareholders shortly.

Enquiries

 
                                   +44 (0)1740 626 
 Kromek Group plc                   060 
 Arnab Basu, CEO 
  Derek Bulmer, CFO 
 
 Cenkos Securities plc             +44 (0)20 7397 8900 
 Bobbie Hilliam (NOMAD) 
  Julian Morse (Sales) 
 
 Luther Pendragon                  +44 (0)20 7618 9100 
 Harry Chathli, Claire Norbury, 
  Alexis Gore 
 
 

About Kromek Group plc

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma photon imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DOCLIFEADSIILID

(END) Dow Jones Newswires

July 10, 2017 07:00 ET (11:00 GMT)

1 Year Kromek Chart

1 Year Kromek Chart

1 Month Kromek Chart

1 Month Kromek Chart

Your Recent History

Delayed Upgrade Clock